Keywords: integrilin, pushes, up, millennium, revenues, pharmaceuticals, recently
Integrilin pushes up Millennium revenues
Article | 22 April 2002
Millennium Pharmaceuticals, which recently completed its $2 billionacquisition of COR Therapeutics (Marketletter December 17, 2001), has reported a net loss of $56.3 million (excluding ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
